lysophosphatidic acid has been researched along with stilbenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, WS; Han, JW; Jeong, KJ; Kim, BK; Kim, YK; Kim, YM; Lee, HY; Lee, J; Park, SY; Yoon, DS | 1 |
| Cho, KH; Jeong, KJ; Kang, J; Kim, H; Lee, HY; Mills, GB; Panupinthu, N; Park, CG | 1 |
2 other study(ies) available for lysophosphatidic acid and stilbenes
| Article | Year |
|---|---|
Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lysophospholipids; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Stilbenes; Transfection; Vascular Endothelial Growth Factor A | 2007 |
EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrol.
Topics: Cell Line, Tumor; ErbB Receptors; Female; Humans; Immunoblotting; Immunoprecipitation; Lysophospholipids; Ovarian Neoplasms; Phosphorylation; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stilbenes | 2013 |